Inhibition of theiler's virus-induced demylination in vivo by tumor necrosis factor alpha

Carlos V. Paya, Paul J. Leibson, Amy K. Patick, Moses Rodriguez

Research output: Contribution to journalArticlepeer-review

49 Scopus citations


Employing a murine model of multiple sclerosis which utilizes intracraniai injection of Theiier's virus murine encephalomyelitis (TMEV) Into SJL/J mice, we tested the potential role of tumor necrosis factor alpha (TNF-a) In ameliorating CNS demyeiination. Infection with TMEV caused early grey matter Inflammation (7 days post-Infection) in the brain and spinal cord followed by chronic demyeiination (35 days post-infection) in the spinal cord. Administration of recombinant human or mouse TNF-a starting 12 h prior to infection and then three times weekly had minimal effect on development of grey matter Inflammation in the spinal cord. In contrast, TNF-a dramatically reduced demyeiination present In spinal cord on days 14 and 35 after TMEV infection (P < 0.01) when compared to controls. CNS virus tlters of TMEV were not modified by TNF-a administration as measured on days 7, 14, and 35 following infection. In vivo administration of TNF-a inhibits TMEV-induced demyeiination in susceptible SJL/J mice without affecting virus replication In the CNS.

Original languageEnglish (US)
Pages (from-to)909-913
Number of pages5
JournalInternational Immunology
Issue number9
StatePublished - Sep 1990


  • Central nervous system
  • Multiple sclerosis
  • Myelin
  • Oligodendrocyte

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Inhibition of theiler's virus-induced demylination in vivo by tumor necrosis factor alpha'. Together they form a unique fingerprint.

Cite this